Latest News
LivaNova PLC
- LivaNova Plc Estimates – GETTEX:LIA
- LivaNova announces Neuromodulation published 36-month results from CORE-VNS
- LivaNova reports 76% seizure reduction in epilepsy study By Investing.com
- LivaNova VNS study shows 76% seizure reduction at 36 months
- 5 minutes with Kathryn Nichol, LivaNova
- LivaNova to Present at UBS, Wolfe, Stifel, and Jefferies Healthcare Conferences in November
- LivaNova PLC (NASDAQ:LIVN): An Affordable Growth Candidate With Reasonable Valuation
- LivaNova stock trades at EUR 70.00 ahead of November 4 results
- Barclays sets USD 105 target and upgrades LivaNova stock
- Barclays upgraded LivaNova stock to Strong Buy
- What LivaNova Doubters Got Wrong
Headlines from the last 30 days, linking to the original publishers. See all market news →